Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Free Newsletter Sign Up

Pfizer Gets Nod From EU Regulator for Covid Drug Paxlovid

Jan. 27, 2022, 2:17 PM

Pfizer Inc.’s Covid-19 pill received backing from the European Union’s drugs regulator, offering a tool to manage coronavirus infections at home and ease the burden on hospitals.

The European Medicines Agency’s expert committee recommended granting a conditional marketing authorization for the antiviral, called Paxlovid, for adults with Covid at risk of developing severe illness. The agency had already said in December that the treatment could be used by adults, in advance of formal approval.

Pfizer’s Paxlovid Covid-19 pill production.
Source: Pfizer Inc.

The prospect of a pill that can be taken at home at the first sign of symptoms is sparking optimism about the course of ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.